We are pleased to share that three abstracts have been accepted for poster presentations at the AACR annual meeting 2023 in Orlando. Our posters highlight the importance of translational research in understanding the biology of the tumor and associated immune response for the identification of new targets and biomarkers, and in the exploration & identification of markers and mechanisms associated with response or resistance to immunotherapies.
Details about our posters are as follows:
| Title: Profiling of immune cell components and soluble factors in ovarian cancer ascites highlights impaired immune environment |
Session Category: Tumor Biology
Session Title: Single Cell and Spatial Considerations of the Tumor Microenvironment
Session Date and Time: Tuesday Apr 18, 2023 1:30 PM – 5:00 PM
Location: Orange County Convention Center, Poster Section 7
Poster Board Number: 18
Abstract Number: 4705
Participant: Imane Nafia, PhD; Chief Scientific Officer, Explicyte
| Title: Cancer-associated fibroblasts promote T-cell exclusion and resistance to immunotherapy in non-small cell lung cancer with tertiary lymphoid structures |
Session Category: Clinical Research Excluding Trials
Session Title: Biomarkers of Therapeutic Benefit 4
Session Date and Time: Tuesday Apr 18, 2023 9:00 AM – 12:30 PM
Location: Orange County Convention Center, Poster Section 37
Poster Board Number: 16
Abstract Number: 4341
Participant: Jean-Philippe Guégan, PhD; Study Director Translational Research, Explicyte
| Title: Cancer-associated fibroblasts promote T-cell exclusion and resistance to immunotherapy in non-small cell lung cancer with tertiary lymphoid structures |
Session Category: Clinical Research Excluding Trials
Session Title: Spatial Proteomics and Transcriptomics 2
Session Date and Time: Wednesday Apr 19, 2023 9:00 AM – 12:30 PM
Location: Orange County Convention Center, Poster Section 43
Poster Board Number: 7
Abstract Number: 6767
Participant: Florent Peyraud, MD; Institut Bergonié / Explicyte
